UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054701
Receipt number R000062510
Scientific Title Cognitive Behavioral Therapy for Persistent Persistent Postural Perceptual Dizziness in Japan: a Pre Post Comparative Study
Date of disclosure of the study information 2024/06/18
Last modified on 2024/12/18 10:42:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cognitive Behavioral Therapy for Persistent Postural Perceptual Dizziness in Japan: a Pre Post Comparative Study

Acronym

Cognitive Behavioral Therapy for Persistent Postural Perceptual Dizziness in Japan

Scientific Title

Cognitive Behavioral Therapy for Persistent Persistent Postural Perceptual Dizziness in Japan: a Pre Post Comparative Study

Scientific Title:Acronym

Cognitive Behavioral Therapy for Persistent Postural Perceptual Dizziness in Japan

Region

Japan


Condition

Condition

Persistent Postural Perceptual Dizziness

Classification by specialty

Oto-rhino-laryngology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The prevalence of dizziness in the general population is estimated to be 20-30%, and among people of working age, 74% have persistent dizziness for more than 6 months and 30% for more than 5 years, resulting in significant social losses due to chronic dizziness. However, treatment is inadequate, in part because much of the chronic vertigo is organically unexplained. The most common form of chronic vertigo is persistent perceptual postural vertigo (PPPD), which has been described as a vicious circle of interaction between psychiatric symptoms such as anxiety and neurophysiological processes, with neurotic tendencies thought to be the underlying cause. Recently, it has been suggested that cognitive behavioural therapy may be effective in the treatment of chronic vertigo, but there are few reports of such therapy in Japan. The aim of this study was to carry out cognitive-behavioural therapy for patients with PPPD, to test its effectiveness, and to develop a programme of cognitive-behavioural therapy for patients with PPPD.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Dizziness Handicap Inventory(DHI)
(Assessments are made at three time points: pre-intervention assessment, post-intervention assessment and follow-up assessment three months after the end of the intervention, using a patient-reported questionnaire).

Key secondary outcomes

Hospital Anxiety and Depression Scale (HADS)
The Niigata PPPD questionnaire (NPQ)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

CBT for PPPD combined with usual care: The CBT for PPPD used in this study is a structured and manualised six-session programme consisting of psychoeducation, goal setting, internal sensory exposure, body scan, behavioural experimentation, behavioural activation, cognitive restructuring and relapse prevention components. It has the following components. A special text and worksheets are provided. During the treatment period, treatment continues as usual; CBT for PPPD is essentially face-to-face.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants were Japanese patients with PPPD aged 20 or older, diagnosed by a physician at Niigata University Hospital Otorhinolaryngology Department after 2020. Consecutive patients who had not received serotonergic antidepressant therapy after PPPD diagnosis, had no dose increase of serotonergic antidepressants prescribed by other departments within the past 3 months prior to PPPD diagnosis, Consecutive patients who were willing to participate in the study, proficient in reading and writing Japanese, and capable of attending regular CBT sessions were included in the study.

Key exclusion criteria

Those who have difficulty in understanding the questions in the self-administered questionnaire.
Other cases deemed inappropriate by the doctor in charge.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Arata
Middle name
Last name Horii

Organization

Niigata University Graduate School of Medical and Dental Sciences

Division name

Department of Otolaryngology, Head and Neck Surgery,

Zip code

951-8510

Address

1-757 Asahimachidori, Chuo-ku, Niigata City, Niigata Prefecture

TEL

025-227-2306

Email

ahorii@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name Tsunehiko
Middle name
Last name Tanaka

Organization

Niigata University

Division name

Faculty of Education Specialized courses educational psychology

Zip code

950-2181

Address

8050, Ikarashi2-no-cho, Nishi-ku, Niigata City 950-2181, Japan

TEL

025-262-5460

Homepage URL


Email

tanakat@ed.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University

Institute

Department

Personal name



Funding Source

Organization

The Ministry of Education, Culture, Sports, Science and Technology (MEXT). Japan Society for the Promotion of Science (JSPS).

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Niigata University

Address

1-757 Asahimachidori, Chuo-ku, Niigata City, Niigata Prefecture

Tel

025-227-2625

Email

ethics@adm.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 07 Month 01 Day

Date of IRB

2019 Year 03 Month 22 Day

Anticipated trial start date

2020 Year 07 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry

2025 Year 04 Month 10 Day

Date trial data considered complete

2025 Year 04 Month 30 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 06 Month 18 Day

Last modified on

2024 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062510